Abstract
Orexins are neuropeptides that have a wide range of physiological effects, and recent studies have suggested that the orexin system may be involved in traumatic brain injury. However, the expression and localization of orexin receptors have not been examined yet under brain injury conditions. In the present study, we used immunohistochemical techniques to investigate the expression of orexin-1 receptor (OX1R) and its time-dependent changes in the mouse brain after controlled cortical impact (CCI) injury. OX1R-like immunoreactivity was first detected 6 h after injury in the surrounding penumbra of the injury. The intensity of this immunoreactivity was increased at 12 h, peaked at day 1, and then decreased from day 2 to day 7. To identify the cellular localization of OX1R, we also performed double-immunohistochemical staining with OX1R and several cell marker antibodies. OX1R-like immunopositive cells were clearly co-localized with immunoreactivity for the neuronal marker NeuN at day 7. It was also expressed on the periphery of cells immunopositive for CD11b, a microglial cell marker, at days 1 and 7. These results suggest that orexin and its receptor may play roles in traumatic brain injury, and that OX1R is induced in neurons and microglial cells after traumatic brain injury.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Adeghate E, Fernandez-Cabezudo M, Hameed R et al (2010) Orexin-1 receptor co-localizes with pancreatic hormones in islet cells and modulates the outcome of streptozotocin-induced diabetes mellitus. PLoS ONE 5:e8587
Baumann CR, Stocker R, Imhof HG et al (2005) Hypocretin-1 (orexin A) deficiency in acute traumatic brain injury. Neurology 65:147–149
Baumann CR, Werth E, Stocker R, Ludwig S, Rassetti CL (2007) Sleep–wake disturbances 6 months after traumatic brain injury: a prospective study. Brain 130:1873–1883
Baumann CR, Bassetti CL, Valko PO et al (2009) Loss of hypocretin (orexin) neurons with traumatic brain injury. Ann Neurol 66:555–559
Block ML, Zecca L, Hong JS (2007) Microglia-mediated neurotoxicity: uncovering the molecular mechanisms. Nat Rev Neurosci 8:57–69
Bramlett HM, Green EJ, Dietrich WD (1999) Exacerbation of cortical and hippocampal CA1 damage due to posttraumatic hypoxia following moderate fluid-percussion brain injury in rats. J Neurosurg 91:653–659
Conti AC, Raghupathi R, Trojanowski JQ, McIntosh TK (1998) Experimental brain injury induces regionally distinct apoptosis during the acute and delayed post-traumatic period. J Neurosci 18:5663–5672
Dauvilliers Y, Baumann CR, Carlander B et al (2003) CSF hypocretin-1 levels in narcolepsy, Kleine–Levin syndrome, and other hypersomnias and neurological conditions. J Neurol Neurosurg Psychiatry 74:1667–1673
de Lecea L, Kilduff TS, Peyron C et al (1998) The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity. Proc Natl Acad Sci U S A 95:322–327
Dixon CE, Clifton GL, Lighthall JW, Yaghmai AA, Hayes RL (1991) A controlled critical impact model of traumatic brain injury in the rat. J Neurosci Methods 39:253–262
Dohi K, Ripley B, Fujiki N et al (2005) CSF hypocretin-1/orexin-A concentrations in patients with subarachnoid hemorrhage (SAH). Peptides 26:2339–2343
Dohi K, Nishino S, Nakamachi T et al (2006) CSF orexin A concentrations and expressions of the orexin-1 receptor in rat hippocampus after cardiac arrest. Neuropeptides 40:245–250
Drouot X, Moutereau S, Nguyen FP et al (2003) Low levels of ventricular CSF orexin/hypocretin in advanced PD. Neurology 61:540–543
Heiler NP (2008) Immunosuppression after traumatic or ischemic CNS damage: it is neuroprotective and illuminates the role of microglial cells. Prog Neurobiol 84:211–233
Hervieu GJ, Cluderay JE, Harrison DC, Roberts JC, Leslie RA (2001) Gene expression and protein distribution of the orexin-1 receptor in the rat brain and spinal cord. Neuroscience 103:777–797
Ida T, Nakahara K, Murakami T, Hanada R, Nakazato M, Murakami N (2000) Possible involvement of orexin in the stress reaction in rats. Biochem Biophys Res Commun 270:318–323
Irving EA, Harrison DC, Babbs AJ et al (2002) Increased cortical expression of the orexin-1 receptor following permanent middle cerebral artery occlusion in the rat. Neurosci Lett 324:53–56
Kreutzberg GW (1996) Microglia: a sensor for pathological events in the CNS. Trends Neurosci 19:312–318
Liu B, Hong JS (2003) Role of microglia in inflammation-mediated neurodegenerative diseases: mechanisms and strategies for therapeutic intervention. J Pharmacol Exp Ther 304:1–7
Marcus JN, Aschkenasi CJ, Lee CE et al (2001) Differential expression of orexin receptors 1 and 2 in the rat brain. J Comp Neurol 435:6–25
Nakamachi T, Endo S, Ohtaki H et al (2005) Orexin-1 receptor expression after global ischemia in mice. Regul Pept 126:49–54
Nishino S, Kanbayashi T (2005) Symptomatic narcolepsy, cataplexy and hypersomnia, and their implications in the hypothalamic hypocretin/orexin system. Sleep Med Rev 9:269–310
Nishino S, Ripley B, Overeem S, Lammers GJ, Mignot E (2000) Hypocretin (orexin) deficiency in human narcolepsy. Lancet 355:39–40
Peyron C, Faraco J, Rogers W et al (2000) A mutation in a case of early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brains. Nat Med 6:991–997
Ripley B, Overeem S, Fujiki N et al (2001) CSF hypocretin/orexin levels in narcolepsy and other neurological conditions. Neurology 57:2253–2258
Rouet-Benzineb P, Rouyer-Fessard C, Jarry A et al (2004) Orexins acting at native OX1 receptor in colon cancer and neuroblastoma cells or at recombinant OX1 receptor suppress cell growth by inducing apoptosis. J Biol Chem 279:45875–45886
Savitz SI, Rosenbaum DM (1998) Apoptosis in neurological disease. Neurosurgery 42:555–574
Stricker-Krongrad A, Beck B (2002) Modulation of hypothalamic hypocretin/orexin mRNA expression by glucocorticoids. Biochem Biophys Res Commun 296:129–133
Suzuki R, Shimojima H, Funabashi H et al (2002) Orexin-1 receptor immunoreactivity in chemically identified target neurons in the rat hypothalamus. Neurosci Lett 324:5–8
Thannickal TC, Moore RY, Nienhuis R et al (2000) Reduced number of hypocretin neurons in human narcolepsy. Neuron 27:469–474
Voisin T, Firar AE, Avondo V, Laburthe M (2006) Orexin-induced apoptosis: the key role of the seven-transmembrane domain orexin type 2 receptor. Endocrinology 147:4977–4984
Acknowledgments
This study was supported in part by grants from the Ministry of Education, Science, Sports and Culture, from a Showa University Grant-in Aid for Innovative Collaborative Research Projects, and from a Special Research Grant-in Aid for Development of Characteristic Education from the Japanese Ministry of Education, Culture, Sports, Science and Technology.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Mihara, Y., Dohi, K., Yofu, S. et al. Expression and Localization of the Orexin-1 Receptor (OX1R) After Traumatic Brain Injury in Mice. J Mol Neurosci 43, 162–168 (2011). https://doi.org/10.1007/s12031-010-9438-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12031-010-9438-6